user avatar
IGCS
@IGCSociety
Uniting the globe in the fight against gynecologic cancers.
igcs.org
Joined December 2015
728
Following
6,510
Followers
  • user avatar
    IGCS
    @IGCSociety
    May 8, 2023
    Today is #WorldOvarianCancerDay! According to Globocan, by 2040, the number of women around the world diagnosed with #OvarianCancer will rise almost 42%. This disease is a global concern, and we need to unite to tackle this disease on all fronts. #NoWomanLeftBehind #WOCD2023
    13K
  • user avatar
    IGCS
    @IGCSociety
    Mar 2, 2023
    The #HPVvaccine is a safe and effective method to prevent HPV and #CervicalCancer, which is this most common of the 6 HPV-related cancers. Protect yourself and your family. Get vaccinated! #OneLessWorry #HPVAwarenessDay
    5.4K
  • user avatar
    IGCS
    @IGCSociety
    Jul 17, 2021
    Please join us in congratulating our IGCS 2021 award recipients! These 12 individuals (and 1 organization) truly deserve worldwide recognition for their contributions to the #gynonc community. They'll be recognized at #IGCS2021. Read about the recipients: igcs.org/awards/
  • user avatar
    IGCS
    @IGCSociety
    Jul 13, 2022
    WATCH: Dr. Rene Pareja's trick shot 🎱 reveals a fun message about the 2022 Annual Global Meeting! Will you be joining Dr. Pareja in NYC? 🍎 🏙️ #IAmGoing #IGCS2022
    00:00
  • user avatar
    IGCS
    @IGCSociety
    Aug 8, 2022
    We honor the life of Mary “Dicey” Jackson Scroggins, beloved friend, mentor, & inspirational advocate. Her vision was limitless, impact great, and she will be dearly missed. Read about her influential life: igcs.org/remembering-di… #RememberingDicey #DiceyScroggins
  • user avatar
    IGCS
    @IGCSociety
    Jan 19, 2023
    Vaccinating girls aged 9–14 could prevent 30–40% of cervical cancer deaths between 2015 and 2030. HPV vaccines work best if delivered prior to exposure to the virus. The World Health Organization recommends vaccinating girls aged 9–14, when most have not started sexual activity.
    4.4K
  • user avatar
    IGCS
    @IGCSociety
    Jan 21, 2023
    Did you know most women with #CervicalCancer experience an asymptomatic period before the disease becomes clinically evident? Early detection through regular screening can prevent the disease from progressing. Now is the perfect time to #GetScreened.
    3.8K
  • user avatar
    IGCS
    @IGCSociety
    Jan 17, 2020
    Kenyans have taken a critical step in preventing cervical cancer. The Ministry of Health is providing every girl in Kenya with Human Papilloma Virus (HPV) vaccination when she reaches the age of 10. More than 800,000 girls will be vaccinated every year. tinyurl.com/t2ny7qm
  • user avatar
    IGCS
    @IGCSociety
    Apr 5, 2024
    Congratulations to IGCS CEO, Mary Eiken, on 8 years of dedication and impact! 🎉✨ Since 2016, Mary has been a driving force in the fight against gynecologic cancers worldwide. Here's to her unwavering commitment and the legacy she continues to build! Congrats @MaryCEiken!
    3.2K
  • user avatar
    IGCS
    @IGCSociety
    Jan 5, 2023
    Let's empower women to choose effective preventative measures against HPV and #CervicalCancer. The elimination of cervical cancer is within reach if vaccination and screening are available to all women, no matter where they live. #DestigmatizeHPV igcs.org/cervical-cance…
    4.4K
  • user avatar
    IGCS
    @IGCSociety
    May 8, 2024
    Today is World Ovarian Cancer Day! According to Globocan’s 2022 projections, the number of women dying from ovarian cancer each year is projected to increase to 350,956 an increase of almost 70% from 2022. #WorldOvarianCancerDay #NoWomanLeftBehind #WOCD2024
    3.4K
  • user avatar
    IGCS
    @IGCSociety
    Oct 13, 2024
    ✨ We’re thrilled to be in Dublin, Ireland, for #IGCS2024! Excited to present The Every Woman Study™: Low- and Middle-Income Edition results and discuss how we can improve the survival and quality of life for women with ovarian cancer globally. Let’s make a difference together!
    2.2K
  • user avatar
    IGCS
    @IGCSociety
    Jan 30, 2022
    The KEYNOTE-826 trial found pembrolizumab (Keytruda) plus chemotherapy with or without bevacizumab (Avastin) resulted in a meaningful improvement in overall survival in patients with recurrent or metastatic #CervicalCancer. Learn more: tinyurl.com/4ws66uuj
  • user avatar
    IGCS
    @IGCSociety
    Jan 12, 2022
    Did you know that about 600,000 women battle #CervicalCancer each year? Although it is the fourth most common cancer among women, it more likely to be treatable if detected early. Be sure to #GetScreened and stay informed about cervical cancer. #CervicalCancerAwarenessMonth.